Please enable JavaScript.
Coggle requires JavaScript to display documents.
Chronic obstructive pulmonary disease (COPD)- preventable, treatable, but…
Chronic obstructive pulmonary disease (COPD)- preventable, treatable, but often progressive disease characterized by chronic inflammation of the airways, lung parenchyma (resp. bronchioles and alveoli), and pulmonary blood vessels.
Types
-
Chronic Bronchitis: the presence of cough and sputum production for at least 3 months in each of 2 consecutive years; independent disease that may precede or follow development of airflow limitation
Risk Factors
-
-
-
prolonged exposure to dust, irritants, or fumes
-
-
-
-
Pathophysiology
defining feature is airflow limitation not fully reversible during forced exhalation; caused by loss of elastic recoil and airflow obstruction caused by mucus hypersecretion, mucosal edema, and bronchospasm
-
-
-
-
Diagnostics
-
-
-
-
-
Arterial Blood Gas (ABG) shows decreased or low pH, low PaO2, elevated PaCO2, and increased HCO3 levels
Pharmacology
anticholinergics
-
long-acting(LAMA)
aclidinium bromide (Tudorza, Pressair)
-
-
-
-
-
Corticosteroids
-
methylprednisolone (Medrol, Solu-Medrol)
-
-
-
Inhaled
-
fluticasone (Flovent HFA, Flovent Dickus, Arnuity Ellipta)
-
-
-
-
-
Leukotriene Modifiers
-
Leukotriene Inhibitors
zileuton (Zyflo, Zylfo CR)
-
-
-
-
Combination Agents
(SAMA/SABA)
ipratropium/albuterol (Combivent Respimat, DuoNeb)
-
-
-
-